Cara Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Cara Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q4 2023.
  • Cara Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2023 was $502K, a 1.62% increase year-over-year.
  • Cara Therapeutics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2023 was $1.99M, a 1.79% increase year-over-year.
  • Cara Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.99M, a 1.79% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.99M $502K +$8K +1.62% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $1.98M $500K +$9K +1.83% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.98M $496K +$9K +1.85% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.97M $494K +$9K +1.86% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $1.96M $494K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $491K +$9K +1.87% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $487K +$9K +1.88% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $485K +$9K +1.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $482K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $478K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $476K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.